A Phase III Trial to Evaluate the Safety and Efficacy of AZD7442 for the Prevention of COVID-19
Latest Information Update: 16 Oct 2020
At a glance
- Drugs Cilgavimab/tixagevimab (Primary)
- Indications COVID 2019 infections
- Focus Registrational; Therapeutic Use
- Sponsors AstraZeneca
- 16 Oct 2020 New trial record